Browse Studies — Arctuva

National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children With Complex Congenital Heart Disease

The purpose of this initiative is to improve care and outcomes for infants with HLHS by expanding the NPC-QIC national registry to gather clinical care process…

Hypoplastic Left Heart Syndrome (HLHS)

Estimated

~$10 – $675

Children's Hospital Medical Center, CincinnatiNCT02852031

Phase 1

Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS)

The goal of this Phase I Open-Label study is to demonstrate the safety and feasibility of VentriGel injection in children with Hypoplastic Left Heart Syndrome …

Hypoplastic Left Heart Syndrome

Estimated

~$10 – $6,250

Emory UniversityNCT06461676

Effect of Fetal Aortic Valvuloplasty on Outcomes. A Prospective Observational Cohort Study With a Comparison Cohort

In one of the most severe congenital heart defects, hypoplastic left heart syndrome (HLHS), the left ventricle is underdeveloped and the prognosis is worse tha…

Congenital Heart DiseaseAortic Valve StenosisFetal Cardiac Disorder+1 more

Estimated

~$10 – $750

Queen Silvia Children's Hospital, Gothenburg, SwedenNCT05386173

Phase 2

Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.

A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connecti…

HLH - Hypoplastic Left Heart SyndromeDORVDILV - Double Inlet Left Ventricle+8 more

Estimated

~$10 – $6,250

Nationwide Children's HospitalNCT04467671